SRSF2 and chronic myelomonocytic leukemia: SRSF2 mutation has been frequently reported in myelodysplastic syndromes (MDS) and CMML patients which is related to shorter OS and may be considered as an adverse prognostic risk factor in MDS, but not in CMML [8], however, which was undetermined in CNL.